{"id":"https://openalex.org/W3097094670","doi":"https://doi.org/10.1158/1557-3125.ras18-ia21","title":"Abstract IA21: Preventing KRAS processing","display_name":"Abstract IA21: Preventing KRAS processing","publication_year":2020,"publication_date":"2020-05-01","ids":{"openalex":"https://openalex.org/W3097094670","doi":"https://doi.org/10.1158/1557-3125.ras18-ia21","mag":"3097094670"},"language":"en","primary_location":{"id":"doi:10.1158/1557-3125.ras18-ia21","doi":"https://doi.org/10.1158/1557-3125.ras18-ia21","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1557-3125.ras18-ia21","pdf_url":null,"source":{"id":"https://openalex.org/S192067876","display_name":"Molecular Cancer Research","issn_l":"1541-7786","issn":["1541-7786","1557-3125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5000314948","display_name":"Anna E. Maciag","orcid":"https://orcid.org/0000-0001-6562-5640","observed_orcids":["https://orcid.org/0000-0001-6562-5640"]},"institutions":[{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4396570585","display_name":"Leidos Biomedical Research Inc. (United States)","ror":"https://ror.org/00bardy64","country_code":"US","type":"company","lineage":["https://openalex.org/I114662689","https://openalex.org/I4396570585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anna Maciag","raw_affiliation_strings":["1Frederick National Laboratory for Cancer Research/Leidos Biomedical Research, Inc., Frederick, MD,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Frederick National Laboratory for Cancer Research/Leidos Biomedical Research, Inc., Frederick, MD,","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4396570585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058777008","display_name":"Yue Yang","orcid":"https://orcid.org/0000-0001-5670-9551","observed_orcids":["https://orcid.org/0000-0001-5670-9551"]},"institutions":[{"id":"https://openalex.org/I1282311441","display_name":"Lawrence Livermore National Laboratory","ror":"https://ror.org/041nk4h53","country_code":"US","type":"facility","lineage":["https://openalex.org/I1282311441","https://openalex.org/I1330989302","https://openalex.org/I198811213","https://openalex.org/I4210138311"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yue Yang","raw_affiliation_strings":["2Lawrence Livermore National Laboratory, Livermore, CA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Lawrence Livermore National Laboratory, Livermore, CA,","institution_ids":["https://openalex.org/I1282311441"]}]},{"author_position":"middle","author":{"id":null,"display_name":"David Turner","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4396570585","display_name":"Leidos Biomedical Research Inc. (United States)","ror":"https://ror.org/00bardy64","country_code":"US","type":"company","lineage":["https://openalex.org/I114662689","https://openalex.org/I4396570585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Turner","raw_affiliation_strings":["1Frederick National Laboratory for Cancer Research/Leidos Biomedical Research, Inc., Frederick, MD,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Frederick National Laboratory for Cancer Research/Leidos Biomedical Research, Inc., Frederick, MD,","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4396570585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015198096","display_name":"Marcin D. Dyba","orcid":"https://orcid.org/0000-0001-6311-6877","observed_orcids":["https://orcid.org/0000-0001-6311-6877"]},"institutions":[{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4396570585","display_name":"Leidos Biomedical Research Inc. (United States)","ror":"https://ror.org/00bardy64","country_code":"US","type":"company","lineage":["https://openalex.org/I114662689","https://openalex.org/I4396570585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marcin Dyba","raw_affiliation_strings":["1Frederick National Laboratory for Cancer Research/Leidos Biomedical Research, Inc., Frederick, MD,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Frederick National Laboratory for Cancer Research/Leidos Biomedical Research, Inc., Frederick, MD,","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4396570585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100733969","display_name":"Vandana Kumari","orcid":"https://orcid.org/0000-0003-3583-6046","observed_orcids":["https://orcid.org/0000-0003-3583-6046"]},"institutions":[{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4396570585","display_name":"Leidos Biomedical Research Inc. (United States)","ror":"https://ror.org/00bardy64","country_code":"US","type":"company","lineage":["https://openalex.org/I114662689","https://openalex.org/I4396570585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vandana Kumari","raw_affiliation_strings":["1Frederick National Laboratory for Cancer Research/Leidos Biomedical Research, Inc., Frederick, MD,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Frederick National Laboratory for Cancer Research/Leidos Biomedical Research, Inc., Frederick, MD,","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4396570585"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Brian Smith","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4396570585","display_name":"Leidos Biomedical Research Inc. (United States)","ror":"https://ror.org/00bardy64","country_code":"US","type":"company","lineage":["https://openalex.org/I114662689","https://openalex.org/I4396570585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brian Smith","raw_affiliation_strings":["1Frederick National Laboratory for Cancer Research/Leidos Biomedical Research, Inc., Frederick, MD,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Frederick National Laboratory for Cancer Research/Leidos Biomedical Research, Inc., Frederick, MD,","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4396570585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100373588","display_name":"Lixin Fan","orcid":"https://orcid.org/0000-0002-9232-9262","observed_orcids":["https://orcid.org/0000-0002-9232-9262"]},"institutions":[{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4396570585","display_name":"Leidos Biomedical Research Inc. (United States)","ror":"https://ror.org/00bardy64","country_code":"US","type":"company","lineage":["https://openalex.org/I114662689","https://openalex.org/I4396570585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lixin Fan","raw_affiliation_strings":["1Frederick National Laboratory for Cancer Research/Leidos Biomedical Research, Inc., Frederick, MD,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Frederick National Laboratory for Cancer Research/Leidos Biomedical Research, Inc., Frederick, MD,","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4396570585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074927235","display_name":"Stephan Gysin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]},{"id":"https://openalex.org/I4210167126","display_name":"UCSF Helen Diller Family Comprehensive Cancer Center","ror":"https://ror.org/05yndxy10","country_code":"US","type":"facility","lineage":["https://openalex.org/I180670191","https://openalex.org/I4210110664","https://openalex.org/I4210167126"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stephan Gysin","raw_affiliation_strings":["3UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA,","institution_ids":["https://openalex.org/I180670191","https://openalex.org/I4210167126"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055354782","display_name":"Andrew L. Wolfe","orcid":"https://orcid.org/0000-0003-0418-716X","observed_orcids":["https://orcid.org/0000-0003-0418-716X"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]},{"id":"https://openalex.org/I4210167126","display_name":"UCSF Helen Diller Family Comprehensive Cancer Center","ror":"https://ror.org/05yndxy10","country_code":"US","type":"facility","lineage":["https://openalex.org/I180670191","https://openalex.org/I4210110664","https://openalex.org/I4210167126"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew Wolfe","raw_affiliation_strings":["3UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA,","institution_ids":["https://openalex.org/I180670191","https://openalex.org/I4210167126"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059546399","display_name":"Hazem Abdelkarim","orcid":"https://orcid.org/0000-0001-7180-0177","observed_orcids":["https://orcid.org/0000-0001-7180-0177"]},"institutions":[{"id":"https://openalex.org/I39422238","display_name":"University of Illinois Chicago","ror":"https://ror.org/02mpq6x41","country_code":"US","type":"education","lineage":["https://openalex.org/I39422238"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hazem Abdelkarim","raw_affiliation_strings":["4University of Illinois at Chicago, College of Medicine, Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4University of Illinois at Chicago, College of Medicine, Chicago, IL","institution_ids":["https://openalex.org/I39422238"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079175978","display_name":"Vadim Gaponenko","orcid":"https://orcid.org/0000-0002-7891-9223","observed_orcids":["https://orcid.org/0000-0002-7891-9223"]},"institutions":[{"id":"https://openalex.org/I39422238","display_name":"University of Illinois Chicago","ror":"https://ror.org/02mpq6x41","country_code":"US","type":"education","lineage":["https://openalex.org/I39422238"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vadim Gaponenko","raw_affiliation_strings":["4University of Illinois at Chicago, College of Medicine, Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4University of Illinois at Chicago, College of Medicine, Chicago, IL","institution_ids":["https://openalex.org/I39422238"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020056606","display_name":"Felice C. Lightstone","orcid":"https://orcid.org/0000-0003-1465-426X","observed_orcids":["https://orcid.org/0000-0003-1465-426X"]},"institutions":[{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4396570585","display_name":"Leidos Biomedical Research Inc. (United States)","ror":"https://ror.org/00bardy64","country_code":"US","type":"company","lineage":["https://openalex.org/I114662689","https://openalex.org/I4396570585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Felice Lightstone","raw_affiliation_strings":["1Frederick National Laboratory for Cancer Research/Leidos Biomedical Research, Inc., Frederick, MD,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Frederick National Laboratory for Cancer Research/Leidos Biomedical Research, Inc., Frederick, MD,","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4396570585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046377031","display_name":"Dwight V. Nissley","orcid":"https://orcid.org/0000-0001-7523-116X","observed_orcids":["https://orcid.org/0000-0001-7523-116X"]},"institutions":[{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4396570585","display_name":"Leidos Biomedical Research Inc. (United States)","ror":"https://ror.org/00bardy64","country_code":"US","type":"company","lineage":["https://openalex.org/I114662689","https://openalex.org/I4396570585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dwight Nissley","raw_affiliation_strings":["1Frederick National Laboratory for Cancer Research/Leidos Biomedical Research, Inc., Frederick, MD,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Frederick National Laboratory for Cancer Research/Leidos Biomedical Research, Inc., Frederick, MD,","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4396570585"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5082685256","display_name":"Frank P. McCormick","orcid":"https://orcid.org/0000-0002-6619-7120","observed_orcids":["https://orcid.org/0000-0002-6619-7120"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]},{"id":"https://openalex.org/I4210167126","display_name":"UCSF Helen Diller Family Comprehensive Cancer Center","ror":"https://ror.org/05yndxy10","country_code":"US","type":"facility","lineage":["https://openalex.org/I180670191","https://openalex.org/I4210110664","https://openalex.org/I4210167126"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Frank McCormick","raw_affiliation_strings":["3UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA,","institution_ids":["https://openalex.org/I180670191","https://openalex.org/I4210167126"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"18","issue":"5_Supplement","first_page":"IA21","last_page":"IA21"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10169","display_name":"Protein Kinase Regulation and GTPase Signaling","score":0.9911999702453613,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10169","display_name":"Protein Kinase Regulation and GTPase Signaling","score":0.9911999702453613,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12104","display_name":"Protein Tyrosine Phosphatases","score":0.002099999925121665,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/kras","display_name":"KRAS","score":0.8840000033378601},{"id":"https://openalex.org/keywords/tipifarnib","display_name":"tipifarnib","score":0.800000011920929},{"id":"https://openalex.org/keywords/farnesyltransferase-inhibitors","display_name":"farnesyltransferase inhibitors","score":0.8029999732971191},{"id":"https://openalex.org/keywords/covalent-inhibitors","display_name":"covalent inhibitors","score":0.6610000133514404},{"id":"https://openalex.org/keywords/oncogenic-kras","display_name":"oncogenic KRAS","score":0.6510000228881836},{"id":"https://openalex.org/keywords/ras-driven-cancers","display_name":"RAS-driven cancers","score":0.675000011920929},{"id":"https://openalex.org/keywords/small-molecule-inhibitors","display_name":"small molecule inhibitors","score":0.6959999799728394}],"concepts":[{"id":"https://openalex.org/C1167327","wikidata":"https://www.wikidata.org/wiki/Q14884140","display_name":"HRAS","level":5,"score":0.8883262276649475},{"id":"https://openalex.org/C2781187634","wikidata":"https://www.wikidata.org/wiki/Q20969980","display_name":"KRAS","level":4,"score":0.829554557800293},{"id":"https://openalex.org/C57790582","wikidata":"https://www.wikidata.org/wiki/Q901141","display_name":"Prenylation","level":3,"score":0.7919125556945801},{"id":"https://openalex.org/C2778396349","wikidata":"https://www.wikidata.org/wiki/Q410994","display_name":"Farnesyltransferase","level":4,"score":0.7838869094848633},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5565339922904968},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5562545657157898},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4603787064552307},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.35039883852005005},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.3282722234725952},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.288381963968277},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.23295095562934875},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.08162564039230347}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1557-3125.ras18-ia21","doi":"https://doi.org/10.1158/1557-3125.ras18-ia21","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1557-3125.ras18-ia21","pdf_url":null,"source":{"id":"https://openalex.org/S192067876","display_name":"Molecular Cancer Research","issn_l":"1541-7786","issn":["1541-7786","1557-3125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.504800021648407,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2461832716","https://openalex.org/W2619686862","https://openalex.org/W2026490817","https://openalex.org/W4254030242","https://openalex.org/W2315593827","https://openalex.org/W4224253719","https://openalex.org/W7094957641","https://openalex.org/W2051626784","https://openalex.org/W2091054428","https://openalex.org/W2055429090"],"abstract_inverted_index":{"Abstract":[0],"Tipifarnib,":[1],"a":[2,81],"drug":[3],"that":[4,62,86,97],"targets":[5],"HRAS":[6,26],"through":[7,115],"inhibiting":[8],"farnesyl":[9,52],"transferase,":[10],"is":[11,87],"in":[12,22,83,103,133],"phase":[13],"II":[14],"clinical":[15],"trials":[16],"and":[17,117,122],"appears":[18],"to":[19,35,80,101],"show":[20],"activity":[21],"tumors":[23],"harboring":[24],"oncogenic":[25,142],"mutations":[27],"(https://kuraoncology.com/pipeline/#tipifarnib).":[28],"Unfortunately,":[29],"these":[30,163],"drugs":[31],"are":[32,131,160],"not":[33,99,147],"expected":[34],"be":[36,46],"effective":[37],"on":[38,210],"KRAS":[39,66,143,153,200],"cancers":[40],"because":[41],"KRAS,":[42],"unlike":[43],"HRAS,":[44],"can":[45],"prenylated":[47],"by":[48,68,89,141,151],"geranylgeranyl":[49],"transferase":[50,53],"following":[51],"inhibition.":[54],"To":[55],"address":[56],"this,":[57],"we":[58,128],"have":[59,129],"developed":[60,130],"compounds":[61,78,127,164],"prevent":[63,136],"farnesylation":[64],"of":[65,75,109,138,205],"4B":[67],"covalent":[69],"reaction":[70],"with":[71,91],"C185,":[72],"the":[73,84,92,206],"site":[74],"prenylation.":[76],"These":[77],"bind":[79],"pocket":[82,111],"G-domain":[85],"formed":[88],"interaction":[90,96],"hypervariable":[93],"region,":[94],"an":[95],"does":[98],"seem":[100],"occur":[102],"other":[104],"RAS":[105],"proteins.":[106],"This":[107],"existence":[108],"this":[110],"has":[112],"been":[113],"demonstrated":[114],"biochemical":[116],"biophysical":[118],"analysis,":[119],"including":[120],"NMR":[121],"small-angle":[123],"X-ray":[124],"scattering.":[125],"The":[126],"active":[132],"cells:":[134],"they":[135],"proliferation":[137],"MEFs":[139,149],"driven":[140],"proteins":[144],"but":[145],"do":[146],"affect":[148],"supported":[150],"myristoylated":[152],"G12D":[154],"C185S":[155],"at":[156],"equivalent":[157],"concentrations.":[158],"We":[159],"currently":[161],"optimizing":[162],"for":[165],"further":[166],"preclinical":[167],"development.":[168],"Citation":[169],"Format:":[170],"Anna":[171],"Maciag,":[172],"Yue":[173],"Yang,":[174],"David":[175],"Turner,":[176],"Marcin":[177],"Dyba,":[178],"Vandana":[179],"Kumari,":[180],"Brian":[181],"Smith,":[182],"Lixin":[183],"Fan,":[184],"Stephan":[185],"Gysin,":[186],"Andrew":[187],"Wolfe,":[188],"Hazem":[189],"Abdelkarim,":[190],"Vadim":[191],"Gaponenko,":[192],"Felice":[193],"Lightstone,":[194],"Dwight":[195],"Nissley,":[196],"Frank":[197],"McCormick.":[198],"Preventing":[199],"processing":[201],"[abstract].":[202],"In:":[203],"Proceedings":[204],"AACR":[207],"Special":[208],"Conference":[209],"Targeting":[211],"RAS-Driven":[212],"Cancers;":[213],"2018":[214],"Dec":[215],"9-12;":[216],"San":[217],"Diego,":[218],"CA.":[219],"Philadelphia":[220],"(PA):":[221],"AACR;":[222],"Mol":[223],"Cancer":[224],"Res":[225],"2020;18(5_Suppl):Abstract":[226],"nr":[227],"IA21.":[228]},"counts_by_year":[],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2020-11-09T00:00:00"}